Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 144 | 164 | +20 |
| Shares | 65.2M | 66.0M | +852.6K (+1.3%) |
| Value | $345.1M | $446.7M | +$101.6M (+29.4%) |
New holders (33)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (13)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Bank of Montreal | 593,007 | $3.07M |
| Winton Group Ltd | 142,529 | $755.0K |
| Summit Global Investments | 130,000 | $689.0K |
| Two Sigma Securities, LLC | 25,664 | $136.0K |
| Sawgrass Asset Management LLC | 21,705 | $115.0K |
| Meeder Asset Management Inc | 18,581 | $99.0K |
| Engineers Gate Manager LP | 15,395 | $82.0K |
| Pictet Asset Management SA | 12,800 | $68.0K |
| Centiva Capital, LP | 11,520 | $62.0K |
| E Fund Management Co., Ltd. | 10,838 | $57.0K |
| Leonteq Securities AG | 4,000 | $21.2K |
| Northwestern Mutual Wealth Management Co | 1 | $0 |
| Delos Wealth Advisors, LLC | 1 | $0 |